Home » Newsletters » BioWorld Science

BioWorld Science

May 19, 1999

View Archived Issues

Company Profile: SLIL Biomedical

Tremacamra reduces cold symptoms, opens new avenues in rhinovirus research

Connetics receives milestone payment from Suntory

Myriad Genetics delivers four potential drug targets for dementia to Bayer

Inflazyme signs collaborative agreement with HMR for asthma and allergy therapeutics

Schering AG: Annual Report 1998

Innovax acquires oral microsphere technology

Positive findings from phase III trial of anti-IgE for allergic rhinitis

Schering expands antibody agreement with Medarex

VIMRx and Nexell restructure relationship with Baxter

SDZ-RAD prolongs survival of pig-to-primate xenotransplantation

Anti-CD3 MAb HuM291 suppresses transplant rejection in clinical trials

Azimilide reduces recurrence in PSVT patients

Novel vitronectin receptor antagonists in early development at SB

New hydroxamic acid-based MMP and TNF-alpha production inhibitors from American Cyanamid

BASF patents new tyrosine kinase inhibitors for hyperproliferative and angiogenic disorders

Lysophosphatidylic acid derivatives for local or systemic treatment of bone metabolic disorders

Inhibitors of key kynurenine pathway enzyme disclosed by Pharmacia & Upjohn

Alosetron provides significant relief of pain and improves bowel function in patients with IBS

Novel agents from Dr. Reddy with hypolipidemic, hypoglycemic and HDL cholesterol-increasing effects

Potent, water-soluble paclitaxel analogue in early clinical trials presented by BMS at ASCO meeting

Phase I results for endothelin antagonist discussed at ASCO meeting; phase II trials under way

RSR-13, an allosteric hemoglobin modifier, evaluated in GBM in combination with cranial radiotherapy

Merger of Sanofi and Synthelabo effective retroactively as of January 1, 1999

Pegylated G-CSF from Roche compared to filgrastim in chemotherapy-treated breast cancer patients

Triangle Pharmaceuticals: Q1 1999 highlights

Encouraging phase I/II data reported at oncology meeting for Incel

News from DDW: dexloxiglumide in the treatment of IBS

Novartis develops new enteric-coated formulation of mycophenolic acid

Transplantation news: tresperimus is a potent immunosuppressant with a novel mechanism of action

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...